Fludarabine, cytarabine, and idarubicin with or without venetoclax in patients with relapsed/refractory acute myeloid leukemia.
Shahswar R, Beutel G, Gabdoulline R, Schwarzer A, Kloos A, Koenecke C, Stadler M, Gohring G, Behrens YL, Li Z, Dallmann LK, Klement P, Albert C, Wichmann M, Alwie Y, Benner A, Saadati M, Ganser A, Thol F, Heuser M.
Shahswar R, et al. Among authors: beutel g.
Haematologica. 2024 Jan 1;109(1):72-83. doi: 10.3324/haematol.2023.282912.
Haematologica. 2024.
PMID: 37470150
Free PMC article.